Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Jamie Enoch, Arevik Ghulakhszian, Mandeep Sekhon, David P Crabb, Deanna J Taylor & Christiana Dinah. (2023) Towards a Therapy for Geographic Atrophy: A Patient’s Experience. Patient Preference and Adherence 17, pages 299-310.
Read now
Read now
Gudrun Reitan, Inga Britt Kjellevold Haugen, Kristoffer Andersen, Ragnheidur Bragadottir & Christian Bindesbøll. (2023) Through the Eyes of Patients: Understanding Treatment Burden of Intravitreal Anti-VEGF Injections for nAMD Patients in Norway. Clinical Ophthalmology 17, pages 1465-1474.
Read now
Read now
Orly Weinstein, Arnon D. Cohen, Jaime Levy, Ofira Zloto, Tamar Freud, Israel Krieger, Doron Comaneshter & Rachel Shemesh. (2023) Anxiety in Patients with Neovascular Age-related Macular Degeneration. Ophthalmic Epidemiology 30:3, pages 286-292.
Read now
Read now
Audrey Giocanti-Aurégan, Alfredo García-Layana, Tunde Peto, Brittany Gentile, Gloria C Chi, Mirela Mirt, Charlotte E Kosmas, Jeremy Lambert, Sally Lanar, Hannah B Lewis & Nancy M Holekamp. (2022) Drivers of and Barriers to Adherence to Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treatment Management Plans: A Multi-National Qualitative Study. Patient Preference and Adherence 16, pages 587-604.
Read now
Read now
Kanji Takahashi, Tomohiro Iida, Susumu Ishida, Bruce Crawford, Yoko Sakai, Akikazu Mochizuki, Ryuta Tsujiuchi, Satoru Tanaka & Kota Imai. (2022) Effectiveness of Current Treatments for Wet Age-Related Macular Degeneration in Japan: A Systematic Review and Pooled Data Analysis. Clinical Ophthalmology 16, pages 531-540.
Read now
Read now
Koby Brosh, Eduardo Roditi, Lauren M. Wasser, Ahmad Aryan, Joel Hanhart & Michael J. Potter. (2022) Effect of Music Selection on Anxiety Level during Intravitreal Injections for Individuals of Varying Cultures. Ophthalmic Epidemiology 29:5, pages 582-587.
Read now
Read now
Anne Thier & Christine Holmberg. (2022) The patients’ view: age-related macular degeneration and its effects – a meta-synthesis. Disability and Rehabilitation 44:5, pages 661-671.
Read now
Read now
Bianka Sobolewska, Muhammed Sabsabi & Focke Ziemssen. (2021) Importance of Treatment Duration: Unmasking Barriers and Discovering the Reasons for Undertreatment of Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration. Clinical Ophthalmology 15, pages 4317-4326.
Read now
Read now
Markus Groppe & Mandeep Singh Bindra. (2021) Restructuring Wet Age-Related Macular Degeneration Services During the COVID-19 Pandemic to Allow Social Distancing Outpatient Clinics (SDOC). Clinical Ophthalmology 15, pages 651-659.
Read now
Read now
Anat Loewenstein & Tiarnan D. L. Keenan. (2021) Perspectives on remote patient monitoring with self-operated OCT for management of neovascular age-related macular degeneration. Expert Review of Ophthalmology 16:6, pages 425-429.
Read now
Read now
Eric R Chen & Peter K Kaiser. (2020) Therapeutic Potential of the Ranibizumab Port Delivery System in the Treatment of AMD: Evidence to Date. Clinical Ophthalmology 14, pages 1349-1355.
Read now
Read now
Kimberly L Spooner, Cleopatra T Mhlanga, Thomas H Hong, Geoffrey K Broadhead & Andrew A Chang. (2018) The burden of neovascular age-related macular degeneration: a patient’s perspective. Clinical Ophthalmology 12, pages 2483-2491.
Read now
Read now
Articles from other publishers (57)
Alison Choi, Baraa S. Nawash, Katherine Du, Joshua Ong & Jay Chhablani. (2024) Barriers to care in neovascular age-related macular degeneration: Current understanding, developments, and future directions. Survey of Ophthalmology 69:1, pages 160-164.
Crossref
Crossref
Jamie Enoch, Arevik Ghulakhszian, Mandeep Sekhon, David P. Crabb, Deanna J. Taylor & Christiana Dinah. (2023) Exploring patient acceptability of emerging intravitreal therapies for geographic atrophy: A mixed-methods study. Eye 37:17, pages 3634-3642.
Crossref
Crossref
Christina Y. Weng, Rishi P. Singh, Mark C. Gillies & Carl D. Regillo. (2023) Optimizing Visual Outcomes in Patients With Neovascular Age-Related Macular Degeneration: the Potential Value of Sustained Anti-VEGF Therapy. Ophthalmic Surgery, Lasers and Imaging Retina 54:11, pages 654-659.
Crossref
Crossref
Taiichi Hikichi. (2023) Investigation of satisfaction with short-term outcomes after switching to faricimab to treat neovascular age-related macular degeneration. Japanese Journal of Ophthalmology 67:6, pages 652-656.
Crossref
Crossref
Jamie Enoch, Arevik Ghulakhszian, Mandeep Sekhon, David P. Crabb, Deanna J. Taylor & Christiana Dinah. (2023) Piloting a forced-choice task to elicit treatment preferences in geographic atrophy. BMC Research Notes 16:1.
Crossref
Crossref
Christina Yiallouridou, Jennifer H Acton, Sanjiv Banerjee, Heather Waterman & Ashley Wood. (2023) Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners. BMJ Open 13:8, pages e069625.
Crossref
Crossref
Jamie Prince, Dipen Kumar, Arko Ghosh, J. Fernando Arevalo & Alice Yang Zhang. (2023) Surgical Management of Diabetic Macular Edema. Current Diabetes Reports 23:6, pages 119-125.
Crossref
Crossref
Levon M. Khachigian, Gerald Liew, Kelvin Y. C. Teo, Tien Y. Wong & Paul Mitchell. (2023) Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration. Journal of Translational Medicine 21:1.
Crossref
Crossref
Kelvin Y. C. Teo, Vuong Nguyen, Louise O’Toole, Vincent Daien, Jorge Sanchez-Monroy, Federico Ricci, Theodorus Leonardus Ponsioen, Helena Brosa Morros, Chui Ming Gemmy Cheung, Jennifer J. Arnold, Daniel Barthelmes & Mark C. Gillies. (2022) Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration. Eye 37:3, pages 467-473.
Crossref
Crossref
Rui Wang, Cynthia K McClard, Stephen Laswell, Raziyeh Mahmoudzadeh, Mirataollah Salabati, Michael Ammar, Jordyn Vannavong, Aamir A Aziz, Amy Ewald, Allison V Calvanese, Erik B Lehman, Sagit Fried, Victoria Windham, Adriana Strutt, Namrata Saroj, Arshad Mohammad Khanani, David A Eichenbaum, Carl Regillo & Charles Clifton Wykoff. (2022) Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII). BMJ Open Ophthalmology 7:1, pages e001188.
Crossref
Crossref
Usha Chakravarthy, Beatriz G. Armendariz & Sascha Fauser. (2022) 15 years of anti-VEGF treatment for nAMD: success or failure or something in between?. Eye 36:12, pages 2232-2233.
Crossref
Crossref
Seán O’Connor, Charlene Treanor, Elizabeth Ward, Robin Wickens, Abby O’Connell, Lucy Culliford, Chris Rogers, Eleanor Gidman, Tunde Peto, Paul Knox, Benjamin Burton, Andrew Lotery, Sobha Sivaprasad, Barnaby Reeves, Ruth Hogg & Michael Donnelly. (2022) Patient Acceptability of Home Monitoring for Neovascular Age-Related Macular Degeneration Reactivation: A Qualitative Study. International Journal of Environmental Research and Public Health 19:20, pages 13714.
Crossref
Crossref
Ana Marta & Bernardete Pessoa. 2022. Recent Advances and New Perspectives in Managing Macular Degeneration. Recent Advances and New Perspectives in Managing Macular Degeneration.
Iréne Jern, Sara Forsell & Helena Norberg. (2022) Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study. BMJ Open 12:9, pages e065001.
Crossref
Crossref
Seán O’Connor, Charlene Treanor, Elizabeth Ward, Robin Wickens, Abby O’Connell, Lucy Culliford, Chris Rogers, Eleanor Gidman, Tunde Peto, Paul Knox, Benjamin Burton, Andrew Lotery, Sobha Sivaprasad, Barnaby Reeves, Ruth Hogg & Michael Donnelly. (2022) The COVID-19 Pandemic and Ophthalmic Care: A Qualitative Study of Patients with Neovascular Age-Related Macular Degeneration (nAMD). International Journal of Environmental Research and Public Health 19:15, pages 9488.
Crossref
Crossref
Marlene Hollaus, Wolf Bühl, Ursula Schmidt-Erfurth & Stefan Sacu. (2021) The Challenges of Treating Neovascular Age-Related Macular Degeneration. Klinische Monatsblätter für Augenheilkunde 239:08, pages 1033-1042.
Crossref
Crossref
Christiana Dinah, Jamie Enoch, Arevik Ghulakhszian, Deanna J. Taylor & David P. Crabb. (2021) Intravitreal treatment for geographic atrophy: coming soon to a patient near you?. Eye 36:5, pages 1121-1123.
Crossref
Crossref
Paola S. Calles-Monar, María R. Sanabria, Ana M. Alonso-Tarancon, Rosa M. Coco-Martin & Agustín Mayo-Iscar. (2022) Modifiable Determinants of Satisfaction with Intravitreal Treatment in Patients with Neovascular Age-Related Macular Degeneration. Drugs & Aging 39:5, pages 355-366.
Crossref
Crossref
Kenneth T. Luu, Jennifer Seal, Michelle Green, Carolyn Winskill & Mayssa Attar. (2022) Effect of Anti‐VEGF Therapy on the Disease Progression of Neovascular Age‐Related Macular Degeneration: A Systematic Review and Model‐Based Meta‐Analysis. The Journal of Clinical Pharmacology 62:5, pages 594-608.
Crossref
Crossref
Julian Riecke & Christophe Valmaggia. (2022) “Treat-and-Extend” Regimen for Exudative Age-Related Macular Degeneration: A Two-Year Retrospective Follow-up Study. Klinische Monatsblätter für Augenheilkunde 239:04, pages 494-499.
Crossref
Crossref
J.I. Fernández-Vigo, B. Burgos-Blasco, C. Calvo-González, M.J. Escobar, H. Shi, M. Jiménez-Santos, A. Valverde-Megías, J. Reche-Frutos, L. López-Guajardo & J. Donate-López. (2022) Assessment of the perception of healthcare barriers and the impact of intravitreal injections on neovascular age-related macular degeneration. Archivos de la Sociedad Española de Oftalmología (English Edition) 97:4, pages 198-204.
Crossref
Crossref
J.I. Fernández-Vigo, B. Burgos-Blasco, C. Calvo-González, M.J. Escobar, H. Shi, M. Jiménez-Santos, A. Valverde-Megías, J. Reche-Frutos, L. López-Guajardo & J. Donate-López. (2022) Evaluación de la percepción de las barreras en la asistencia sanitaria y del impacto de las inyecciones intravítreas en la degeneración macular asociada a la edad neovascular. Archivos de la Sociedad Española de Oftalmología 97:4, pages 198-204.
Crossref
Crossref
Valentina Perrone, Melania Dovizio, Chiara Veronesi, Rita Citraro, Adele De Francesco, Stefania Dell’Orco, Gianluca Di Manno, Arrigo Paciello, Anna Maria Resta, Fabrizio Quarta, Nicola Ferrante, Daniela Ritrovato & Luca Degli Esposti. (2022) Retrospective Analysis of the Pharmaco-Utilization of VEGF Inhibitors and Health Care Costs among Patients with Wet Age-Related Macular Degeneration and Other Ocular Diseases in Italy. International Journal of Environmental Research and Public Health 19:5, pages 2548.
Crossref
Crossref
Tatiana R. Rosenblatt, Nadim Rayess, Ahmad Al-Moujahed, Rahul N. Khurana & Prithvi Mruthyunjaya. (2021) Discontinuation and loss to follow-up rates in clinical trials of intravitreal anti-vascular endothelial growth factor injections. Graefe's Archive for Clinical and Experimental Ophthalmology 260:1, pages 93-100.
Crossref
Crossref
Paolo Corazza, Francesco Maria D’Alterio, Jamil Kabbani, Mostafa Mohamed Ragheb Alam, Stefano Mercuri, Harry Otway Orlans & Saad Younis. (2021) Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study. BMC Ophthalmology 21:1.
Crossref
Crossref
Pengxiang Zhou, Siqian Zheng, Ente Wang, Peng Men & Suodi Zhai. (2021) Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 12.
Crossref
Crossref
Matthew S. Wieder, Moshe Szlechter, Noam Fischman, Steven Inker, Irene Rusu & Joyce N. Mbekeani. (2021) Impact of Anxiety Levels and Sleep Patterns on Perceived Pain During Intravitreal Bevacizumab Injections. Ophthalmic Surgery, Lasers and Imaging Retina 52:9, pages 498-504.
Crossref
Crossref
Albrecht Lommatzsch, Nicole Eter, Christoph Ehlken, Ines Lanzl, Hakan Kaymak, Alexander K. Schuster & Focke Ziemssen. (2020) Adhärenz bei der Anti-VEGF-Therapie – Überlegungen und praktische EmpfehlungenAdherence to anti-VEGF treatment—Considerations and practical recommendations. Der Ophthalmologe 118:8, pages 801-809.
Crossref
Crossref
Fumi Gomi, Reiko Toyoda, Annabelle Hein Yoon & Kota Imai. (2021) Factors of Anti-Vascular Endothelial Growth Factor Therapy Withdrawal in Patients with Neovascular Age-Related Macular Degeneration: Implications for Improving Patient Adherence. Journal of Clinical Medicine 10:14, pages 3106.
Crossref
Crossref
Hilde PA van der Aa, Ger HMB van Rens, Frank D Verbraak, Machteld Bosscha, Hannie C Comijs & Ruth MA van Nispen. (2021) Anxiety and depression in patients who receive anti‐VEGF treatment and the usability and feasibility of e‐mental health support: the E‐PsEYE pilot study. Ophthalmic and Physiological Optics 41:4, pages 808-819.
Crossref
Crossref
Mali Okada, Tien Yin Wong, Paul Mitchell, Bora Eldem, S. James Talks, Tariq Aslam, Vincent Daien, Francisco J. Rodriguez, Richard Gale, Jane Barratt, Robert P. Finger & Anat Loewenstein. (2021) Defining Nonadherence and Nonpersistence to Anti–Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration. JAMA Ophthalmology 139:7, pages 769.
Crossref
Crossref
Karen Marie Poulsen, Tina Jensen & Karin Bundgaard. (2021) Hvordan kan medinddragende rehabilitering understøtte livskvaliteten hos patienter med AMD?. Klinisk Sygepleje 35:2, pages 99-113.
Crossref
Crossref
Tiarnan D.L. Keenan, Michaella Goldstein, Dafna Goldenberg, Dinah Zur, Shiri Shulman & Anat Loewenstein. (2021) Prospective, Longitudinal Pilot Study. Ophthalmology Science 1:2, pages 100034.
Crossref
Crossref
Cynthia K McClard, Rui Wang, Victoria Windham, Jose Munoz, Samuel Gomez, Sagit Fried, Namrata Saroj, Carl Regillo, Charles Clifton Wykoff & Adriana M Strutt. (2021) Questionnaire to Assess Life Impact of Treatment by Intravitreal Injections (QUALITII): Development of a patient-reported measure to assess treatment burden of repeat intravitreal injections. BMJ Open Ophthalmology 6:1, pages e000669.
Crossref
Crossref
Jamie Enoch, Arevik Ghulakhszian, David P Crabb, Christiana Dinah & Deanna J Taylor. (2021) Acceptability of intravitreal injections in geographic atrophy: protocol for a mixed-methods pilot study. BMJ Open 11:4, pages e049495.
Crossref
Crossref
Claire M. GelfmanRuslan GrishaninKristina Oresic BenderAivan NguyenJudith GreengardPallavi SharmaJulio NievesSzilárd KissMehdi Gasmi. (2021) Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema. Journal of Ocular Pharmacology and Therapeutics 37:3, pages 181-190.
Crossref
Crossref
Therlinder Lo, Daniella Lent-Schochet, Kieu-Yen Luu, Ajay E. Kuriyan, Menachem Y. Weiss, Aleksandra V. Rachitskaya, Rishi P. Singh, Karen M. Wai, J. Peter Campbell, Kishan Gupta, Eric Nudleman, Kevin C. Chen & Glenn Yiu. (2021) Patterns and Predictors of Successful Treatment Discontinuation in Retinal Vein Occlusions With Macular Edema in the Real World. Ophthalmic Surgery, Lasers and Imaging Retina 52:2, pages 84-92.
Crossref
Crossref
Mali Okada, Paul Mitchell, Robert P. Finger, Bora Eldem, S. James Talks, Ceri Hirst, Luciano Paladini, Jane Barratt, Tien Yin Wong & Anat Loewenstein. (2021) Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration. Ophthalmology 128:2, pages 234-247.
Crossref
Crossref
Tomohiro Nizawa, Masayasu Kitahashi, Takayuki Baba, Takehito Iwase, Mariko Kubota-Taniai, Yoko Hattori, Yuki Shiko, Yohei Kawasaki, Takayuki Iwase, Takatoshi Sato, Shoko Ogawa, Takeshi Sugawara & Shuichi Yamamoto. (2021) Improvements of Retinal Sensitivity after Intravitreal Injection of Aflibercept in Eyes with Neovascular Age-Related Macular Degeneration with or without Polypoidal Choroidal Vasculopathy. Ophthalmologica 244:4, pages 347-360.
Crossref
Crossref
V. Gualino, E. Fourmaux, T. Grenet, J. Zerbib & B. Wolff. (2020) Patient experience of anti-vegf intravitreal injection. Journal Français d'Ophtalmologie 43:10, pages 1047-1053.
Crossref
Crossref
Christoph Ehlken, Focke Ziemssen, Nicole Eter, Ines Lanzl, Hakan Kaymak, Albrecht Lommatzsch & Alexander K. Schuster. (2020) Systematic review: non-adherence and non-persistence in intravitreal treatment. Graefe's Archive for Clinical and Experimental Ophthalmology 258:10, pages 2077-2090.
Crossref
Crossref
Rituparna Ghoshal, Sharanjeet Sharanjeet-Kaur, Norliza Mohamad Fadzil, Somnath Ghosh, Nor Fariza Ngah & Roslin Azni Abd Aziz. (2020) Patient-Perceived Benefit of Treatment in Polypoidal Choroidal Vasculopathy: A Pilot Study. International Journal of Environmental Research and Public Health 17:17, pages 6378.
Crossref
Crossref
Szilárd Kiss, Ruslan Grishanin, Aivan Nguyen, Romeo Rosario, Judith S. Greengard, Julio Nieves, Claire M. Gelfman & Mehdi Gasmi. (2020) Analysis of Aflibercept Expression in NHPs following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for nAMD. Molecular Therapy - Methods & Clinical Development 18, pages 345-353.
Crossref
Crossref
F. G. Holz, K. T. Johnson, U. Bauer-Steinhusen, C. Rech, T. Machewitz, S. Müller & R. P. Finger. (2019) ANDROMEDA – Eine Untersuchung von Einflussfaktoren auf die Adhärenz von Patienten mit neovaskulärer altersabhängiger Makuladegeneration mithilfe des neu konzipierten Patientenfragebogens LAF-IVTANDROMEDA—an investigation of factors influencing the adherence of patients with neovascular age-related macular degeneration using the newly developed patient questionnaire LAF-IVT. Der Ophthalmologe 117:8, pages 765-774.
Crossref
Crossref
Kun Hae Kim, Soo Hyun Lim & Jae Hui Kim. (2020) Hemodynamic Change after Intravitreal Anti-vascular Endothelial Growth Factor Injection. Journal of Retina 5:1, pages 23-28.
Crossref
Crossref
Masahito Ohji, Paolo Lanzetta, Jean-Francois Korobelnik, Piotr Wojciechowski, Vanessa Taieb, Celine Deschaseaux, Daniel Janer & Claudia Tuckmantel. (2020) Efficacy and Treatment Burden of Intravitreal Aflibercept Versus Intravitreal Ranibizumab Treat-and-Extend Regimens at 2 Years: Network Meta-Analysis Incorporating Individual Patient Data Meta-Regression and Matching-Adjusted Indirect Comparison. Advances in Therapy 37:5, pages 2184-2198.
Crossref
Crossref
Nicole Eter, Daniel Pauleikhoff, Hansjürgen Agostini, Monika Fleckenstein & Focke Ziemssen. (2020) Stellenwert und Formate der QualitätssicherungValue and formats of quality assurance. Der Ophthalmologe.
Crossref
Crossref
Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, Anat Loewenstein & Francesco Bandello. (2019) Brolucizumab: is extended VEGF suppression on the horizon?. Eye 34:3, pages 424-426.
Crossref
Crossref
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Baruch D Kuppermann, Francesco Bandello & Carl D. Regillo. (2019) Ranibizumab port delivery system (RPDS): realising long awaited dream of prolonged VEGF suppression. Eye 34:3, pages 422-423.
Crossref
Crossref
Amir Rosenblatt, Patricia Udaondo, José Cunha-Vaz, Sobha Sivaprasad, Francesco Bandello, Paolo Lanzetta, Laurent Kodjikian, Michaella Goldstein, Zohar Habot-Wilner, Anat Loewenstein, Amir Rosenblatt, Patricia Udaondo, Jose Juan Escobar, Geeta Menon, Sobha Sivaprasad, Borja Corcostegui, Urban Eriksson, Anna Boixadera, Francesco Bandello, Laura Sararols, Laurent Kodjikian, Sebastien Guigou, Monica Varano, João Figueira, Ayalla Pollack, Pascale Massin, Paolo Carpineto, Nicola Recchimurzo, Frederic Matonti, Kati Kinnunen, Paolo Lanzetta, Florence Coscas, Edoardo Midena, João Nascimento, Felix Armada, José Cunha-Vaz, Nir Sorkin, Zohar Habot- Wilner, Michaella Goldstein & Anat Loewenstein. (2020) A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema. Ophthalmology 127:3, pages 377-393.
Crossref
Crossref
Meera S. Ramakrishnan, Yinxi Yu & Brian L. VanderBeek. (2020) Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration. JAMA Ophthalmology.
Crossref
Crossref
Jordi Monés, Rishi P. Singh, Francesco Bandello, Eric Souied, Xin Liu & Richard Gale. (2020) Undertreatment of Neovascular Age-Related Macular Degeneration after 10 Years of Anti-Vascular Endothelial Growth Factor Therapy in the Real World: The Need for A Change of Mindset. Ophthalmologica 243:1, pages 1-8.
Crossref
Crossref
Orla C. Sheehan, Bruce Leff, Christine S. Ritchie, Sarah K. Garrigues, Lingsheng Li, Debra Saliba, Roya Fathi & Cynthia M. Boyd. (2019) A systematic literature review of the assessment of treatment burden experienced by patients and their caregivers. BMC Geriatrics 19:1.
Crossref
Crossref
Cheryl L. Rowe-Rendleman. (2019) Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology. Pharmaceutical Research 36:4.
Crossref
Crossref
Ruslan Grishanin, Brian Vuillemenot, Pallavi Sharma, Annahita Keravala, Judith Greengard, Claire Gelfman, Mark Blumenkrantz, Matthew Lawrence, Wenzheng Hu, Szilárd Kiss & Mehdi Gasmi. (2019) Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration. Molecular Therapy 27:1, pages 118-129.
Crossref
Crossref
Theodoros P. Marakis, Chrysanthi Koutsandrea, Klio I. Chatzistefanou & Yannis Tountas. (2017) Treatment satisfaction of patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor agents. International Ophthalmology 38:2, pages 565-576.
Crossref
Crossref
Charles C. Wykoff, W. Lloyd Clark, Jared S. Nielsen, Joel V. Brill, Laurence S. Greene & Cherilyn L. Heggen. (2018) Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration. Journal of Managed Care & Specialty Pharmacy 24:2-a Suppl, pages S3-S15.
Crossref
Crossref